Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04468841 · ClinicalTrials.gov registry record · Phase 1

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

A Phase 1 study of Follicular Lymphoma, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
Phase 1
Development phase
100
Enrollment target
7
Study locations

NCT04468841 is a Phase 1 study of Follicular Lymphoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 100 participants, below the 134-participant average among 89 other Follicular Lymphoma trials with a reported enrollment target (25% lower). The trial reports 7 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04468841, a Phase 1 study of Follicular Lymphoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
Phase 1
Development phase
100 participants
Enrollment target
7
Study locations

Study Summary

The researchers are doing this study to measure and test cell-free DNA (cfDNA) in the blood before, during, and after first-line treatment for follicular lymphoma. They will look at whether cfDNA levels are related to a person's response to the usual first-line treatment for follicular lymphoma. Researchers also want to understand how different genetic changes in follicular lymphoma relate to a person's response to the usual first-line treatment.

Conditions Studied

Follicular Lymphoma

Interventions

  • DIAGNOSTIC_TEST cfDNA testing
  • OTHER sample of saliva or fingernail clipping
  • DIAGNOSTIC_TEST pre-treatment test specimen
  • DIAGNOSTIC_TEST PET/CT, CT, or MRI testing

Study Locations (7)

New York

  • Memorial Sloan Kettering Commack (All Protocol Activities) - Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (All protocol activities) - Middletown
  • Memorial Sloan Kettering Bergen (All protocol Activities) - Montvale

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-07-08
Est. Completion 2026-07
Phase Phase 1

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04468841

The ClinicalTrials.gov registry entry for NCT04468841 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 134-participant average among 89 other Follicular Lymphoma trials with a reported enrollment target (25% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Follicular Lymphoma appearing as the primary indexed condition, and to 4 interventions - of which cfDNA testing is the first listed.

NCT04468841 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT04468841 about?

NCT04468841 is a clinical study titled "Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma". The researchers are doing this study to measure and test cell-free DNA (cfDNA) in the blood before, during, and after first-line treatment for follicular lymphoma. They will look at whether cfDNA levels are related to a person's response to the usual first-line treatment for follicular lymphoma. Res...

What is the current status of trial NCT04468841?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2020-07-08. Estimated completion is 2026-07.

What conditions does trial NCT04468841 study?

This clinical trial studies the following conditions: Follicular Lymphoma.

What interventions are being tested in trial NCT04468841?

The interventions under investigation include: cfDNA testing (DIAGNOSTIC_TEST), sample of saliva or fingernail clipping (OTHER), pre-treatment test specimen (DIAGNOSTIC_TEST), PET/CT, CT, or MRI testing (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04468841?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04468841 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Follicular Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Follicular Lymphoma

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.